Literature DB >> 18929054

Primary care for children and adolescents with Down syndrome.

Melissa A Davidson1.   

Abstract

This article reviews the general health care guidelines pertaining to pediatric patients with Down syndrome and presents, in a systems-based approach, an update of the current evidence behind these guidelines. To ensure the best possible long-term outcome for these patients, clinicians should provide routine well-child examinations and immunizations while maintaining a high index of suspicion for comorbid conditions more common in Down syndrome. The primary care provider should be prepared to provide information on community resources, to coordinate care with subspecialists, and to refer to early intervention services as soon as the diagnosis is made.

Entities:  

Mesh:

Year:  2008        PMID: 18929054     DOI: 10.1016/j.pcl.2008.07.001

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  14 in total

1.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

Review 2.  Communicating genetic risk information for common disorders in the era of genomic medicine.

Authors:  Denise M Lautenbach; Kurt D Christensen; Jeffrey A Sparks; Robert C Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2013       Impact factor: 8.929

3.  GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder.

Authors:  Su Han Lum; Soo Sin Choong; Shekhar Krishnan; Zulqarnain Mohamed; Hany Ariffin
Journal:  Singapore Med J       Date:  2016-06       Impact factor: 1.858

4.  Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors.

Authors:  Kathryn B Sheets; Blythe G Crissman; Cori D Feist; Susan L Sell; Lisa R Johnson; Kelly C Donahue; Diane Masser-Frye; Gail S Brookshire; Amanda M Carre; Danielle Lagrave; Campbell K Brasington
Journal:  J Genet Couns       Date:  2011-05-27       Impact factor: 2.537

5.  Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.

Authors:  Marwan N Sabbagh; Kewei Chen; Joseph Rogers; Adam S Fleisher; Carolyn Liebsack; Dan Bandy; Christine Belden; Hillary Protas; Pradeep Thiyyagura; Xiaofen Liu; Auttawut Roontiva; Ji Luo; Sandra Jacobson; Michael Malek-Ahmadi; Jessica Powell; Eric M Reiman
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

6.  pyPheWAS: A Phenome-Disease Association Tool for Electronic Medical Record Analysis.

Authors:  Cailey I Kerley; Shikha Chaganti; Tin Q Nguyen; Camilo Bermudez; Laurie E Cutting; Lori L Beason-Held; Thomas Lasko; Bennett A Landman
Journal:  Neuroinformatics       Date:  2022-01-03

7.  Adaptive behavior in infants and toddlers with Down syndrome and fragile X syndrome.

Authors:  Elizabeth A Will; Kelly E Caravella; Laura J Hahn; Deborah J Fidler; Jane E Roberts
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-02-05       Impact factor: 3.568

Review 8.  Revisiting Down syndrome from the ENT perspective: review of literature and recommendations.

Authors:  Maria Ramia; Umayya Musharrafieh; Wajdi Khaddage; Alain Sabri
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-21       Impact factor: 2.503

9.  C2/3 instability: unusual cause of cervical myelopathy in a child with Down syndrome.

Authors:  Amro Al-Habib; Ahmed AlAqeel
Journal:  Childs Nerv Syst       Date:  2012-10-30       Impact factor: 1.475

10.  Prenatal histological, cellular, and molecular anomalies in trisomy 21 lung.

Authors:  Soula Danopoulos; Soumyaroop Bhattacharya; Gail Deutsch; Lina R Nih; Chris Slaunwhite; Thomas J Mariani; Denise Al Alam
Journal:  J Pathol       Date:  2021-06-23       Impact factor: 9.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.